Aimee Weisner
Director/Board Member at GLAUKOS CORPORATION
Net worth: 5 M $ as of 2024-03-30
Profile
Aimee S.
Weisner is currently the Director at STAAR Surgical Co., Independent Director at LENSAR, Inc., Independent Director at Glaukos Corp., Director at NeuroSigma, Inc., and Director at American Heart Association of Orange County.
Previously, she served as the Independent Director at Oyster Point Pharma, Inc. from 2019 to 2023.
She also held positions as Director at Avellino Labs USA, Inc., Corporate Counsel & Assistant Secretary at Allergan, Inc. from 1998 to 2002, Vice President & General Counsel at Edwards Lifesciences Corp.
from 2011 to 2019, Secretary, EVP-Administration & General Counsel at Advanced Medical Optics, Inc. in 2002, and Associate at O'Melveny & Myers LLP from 1994 to 1998.
Ms. Weisner obtained an undergraduate degree from California State University-Fullerton and a graduate degree from Loyola Law School in 1994.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GLAUKOS CORP
0.09% | 2024-01-01 | 45,403 ( 0.09% ) | 4 M $ | 2024-03-30 |
STAAR SURGICAL COMPANY
0.02% | 2024-03-13 | 10,864 ( 0.02% ) | 415 874 $ | 2024-03-30 |
LENSAR INC
0.48% | 2023-06-01 | 54,285 ( 0.48% ) | 184 406 $ | 2024-03-30 |
Aimee Weisner active positions
| Companies | Position | Start |
|---|---|---|
| GLAUKOS CORPORATION | Director/Board Member | 2014-06-30 |
| LENSAR, INC. | Director/Board Member | 2021-01-31 |
| STAAR SURGICAL COMPANY | Director/Board Member | 2022-06-15 |
NeuroSigma, Inc.
 NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Director/Board Member | 2013-12-31 |
| American Heart Association of Orange County | Director/Board Member | 2016-12-31 |
Former positions of Aimee Weisner
| Companies | Position | End |
|---|---|---|
| OYSR POIN | Director/Board Member | 2023-01-02 |
| EDWARDS LIFESCIENCES CORPORATION | General Counsel | 2019-06-30 |
Advanced Medical Optics, Inc.
 Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Chief Administrative Officer | 2008-12-31 |
| ALLERGAN, INC. | General Counsel | - |
| ░░░░░░░░░░░░░░ ░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Aimee Weisner
| California State University-Fullerton | Undergraduate Degree |
| Loyola Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| STAAR SURGICAL COMPANY | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| LENSAR, INC. | Health Technology |
| GLAUKOS CORPORATION | Health Technology |
| Private companies | 7 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Health Technology |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
O'Melveny & Myers LLP
 O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services O'Melveny & Myers LLP provides legal services. Its practice areas include labor and employment, litigation, tax, and transactions. The firm serves high-tech companies in the areas of legal advice related to software licensing, intellectual property, and venture capital investments. The company was founded by Henry William O'Melveny in 1885 and is headquartered in Los Angeles. CA. | Commercial Services |
| American Heart Association of Orange County | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Avellino Labs USA, Inc.
 Avellino Labs USA, Inc. Medical/Nursing ServicesHealth Services Avellino Lab USA, Inc. engages in the provision of diagnostic testing services. It focuses on developing genetic tests for eye care professionals. It also involves in research and development activities related to genetic diagnostics for the prediction and prevention of eye conditions. The company was founded by Gene Lee in 2008 and is headquartered in Menlo Park, CA. | Health Services |
- Stock Market
- Insiders
- Aimee Weisner
